Virtual Reality for Abdominal Pain in Crohn's Disease
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if you are using opioids, you will not be eligible to participate.
What data supports the effectiveness of the treatment Virtual Reality Therapy for abdominal pain in Crohn's Disease?
Is Virtual Reality Therapy safe for people with Crohn's Disease?
How is Virtual Reality Therapy different from other treatments for abdominal pain in Crohn's disease?
What is the purpose of this trial?
The purpose of this research is to see if patients with Crohn's disease (CD) and abdominal pain resulting in health-related quality of life deficits despite lack of evidence of active inflammation improve with the use of virtual reality (VR).
Research Team
Jami Kinnucan, MD
Principal Investigator
Mayo Clinic
Eligibility Criteria
This trial is for individuals with Crohn's disease who are not currently experiencing active inflammation but suffer from abdominal pain that affects their quality of life. The specific eligibility criteria to join the study have not been provided.Inclusion Criteria
Exclusion Criteria
Timeline
Pre-screening
Participants undergo a two-week pre-screening evaluation for symptoms through questionnaires
Treatment
Participants use a VR headset daily for at least 30 minutes over 8 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Virtual Reality
Virtual Reality is already approved in United States for the following indications:
- Functional Dyspepsia
- Irritable Bowel Syndrome (IBS)
- Gastroparesis
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor